Kymera Therapeutics Files 8-K
Ticker: KYMR · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1815442
| Field | Detail |
|---|---|
| Company | Kymera Therapeutics, Inc. (KYMR) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory, financials
Related Tickers: KYMR
TL;DR
Kymera dropped an 8-K on 6/25 - check for Reg FD, other events, and financials.
AI Summary
Kymera Therapeutics, Inc. filed an 8-K on June 25, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company is incorporated in Delaware and its principal executive offices are located in Watertown, Massachusetts.
Why It Matters
This 8-K filing provides updates on regulatory disclosures, other significant events, and financial statements for Kymera Therapeutics, Inc., offering insights into the company's ongoing operations and compliance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting standard disclosures and events, not indicating any immediate material adverse changes.
Key Players & Entities
- Kymera Therapeutics, Inc. (company) — Registrant
- June 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39460 (identifier) — Commission File Number
- 81-2992166 (identifier) — I.R.S. Employer Identification No.
- 500 North Beacon Street, 4th Floor (address) — Address of principal executive offices
- Watertown (location) — City of principal executive offices
- Massachusetts (location) — State of principal executive offices
- 02472 (zip_code) — Zip code of principal executive offices
- (857) 285-5300 (phone_number) — Registrant's telephone number
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a 'Regulation FD Disclosure' but does not specify the exact nature of the disclosure within the provided text.
What are the 'Other Events' reported by Kymera Therapeutics?
The filing lists 'Other Events' as a category of information being reported, but the specific details of these events are not detailed in the provided excerpt.
What is the significance of the 'Financial Statements and Exhibits' section?
This section indicates that the filing includes financial statements and exhibits, which are crucial for understanding the company's financial health and operational details.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 25, 2025.
What is Kymera Therapeutics' primary business classification?
Kymera Therapeutics, Inc. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with the SIC code [2836].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding Kymera Therapeutics, Inc. (KYMR).